echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The sales in the first half of the year exceeded 2 billion!

    The sales in the first half of the year exceeded 2 billion!

    • Last Update: 2021-08-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On July 17, Cansino released the 2021 semi-annual performance forecast.




    In February 2021, the State Food and Drug Administration has conditionally approved CanSino’s application for the registration of the adenovirus vector new crown vaccine.


    Judging from the disclosed report for the first quarter of 2021, although the sales time is relatively short, the new crown vaccine still helped CanSino achieve a revenue of about 467 million yuan, more than 1,100 times the same period last year, and a net loss of 14.





    In addition, it is worth mentioning that, in addition to Cansino, China Biopharmaceuticals previously disclosed its financial report for the first quarter of 2021.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.